Bath & Body Works (NYSE: BBWI) stock: the official figures
Bath & Body Works (BATH & BODY WORKS, INC.) is listed on the New York Stock Exchange under the ticker BBWI and belongs to the consumer discretionary sector. In fiscal 2026 it reported revenue of $7,291m and a net profit of $649.0m, according to the annual accounts it filed with the regulator. Its fiscal year ends on 31 January.
Identifiers for Bath & Body Works: SEC CIK 701985.
Fiscal 2026 figures
| Item | 2026 | 2025 | Change |
|---|---|---|---|
| Revenue | $7,291m | $7,307m | −0.2% |
| Operating profit | $1,126m | $1,266m | −11.1% |
| Net profit | $649.0m | $798.0m | −18.7% |
| Earnings per share | $3.12 | $3.62 | −13.8% |
| Operating margin | 15.4% | 17.3% | −1.9 pts |
| Net margin | 8.9% | 10.9% | −2.0 pts |
| Total assets | $5,069m | $4,872m | +4.0% |
| Equity | −$1,281m | −$1,385m | — |
| Cash | $953.0m | $674.0m | +41.4% |
| Operating cash flow | $1,102m | $886.0m | +24.4% |
Margins are calculated from the filed figures: operating profit and net profit over revenue.
10 fiscal years
| Fiscal year | Revenue | Operating profit | Net profit | Earnings per share | Document |
|---|---|---|---|---|---|
| 2026 | $7,291m | $1,126m | $649.0m | $3.12 | Annual report |
| 2025 | $7,307m | $1,266m | $798.0m | $3.62 | Annual report |
| 2024 | $7,429m | $1,285m | $878.0m | $3.86 | Annual report |
| 2023 | $7,560m | $1,376m | $800.0m | $3.45 | Annual report |
| 2022 | $7,882m | $2,009m | $1,333m | $4.96 | Annual report |
| 2021 | $6,434m | $1,604m | $844.0m | $3.04 | Annual report |
| 2020 | $5,405m | $1,040m | −$366.0m | −$1.33 | Annual report |
| 2019 | $13,237m | $1,237m | $644.0m | $2.33 | Annual report |
| 2018 | $12,632m | $1,728m | $983.0m | $3.46 | Annual report |
| 2017 | $12,574m | $2,003m | $1,158m | $4.04 | Annual report |
The full income statement, balance sheet and cash flow statement are in the annual accounts of Bath & Body Works. Year by year: dividends paid. Purchases and sales by its executives and directors are in insider transactions.
Dividends
In fiscal 2026, Bath & Body Works paid $167.0m in dividends, 25.7% of its net profit, according to its cash flow statement.
| Fiscal year | Dividends paid | Share of net profit |
|---|---|---|
| 2026 | $167.0m | 25.7% |
| 2025 | $177.0m | 22.2% |
| 2024 | $182.0m | 20.7% |
| 2023 | $186.0m | 23.3% |
| 2022 | $120.0m | 9.0% |
| 2021 | $83.0m | 9.8% |
| 2020 | $332.0m | — |
| 2019 | $666.0m | 103.4% |
| 2018 | $686.0m | 69.8% |
| 2017 | $1,268m | 109.5% |
Cash paid out as dividends during the fiscal year, including dividends to minority shareholders of subsidiaries when the company does not report them separately. It is not the dividend per share.
Frequently asked questions about Bath & Body Works
- How much did Bath & Body Works earn in fiscal 2026?
- Bath & Body Works reported a net profit of $649.0m for fiscal 2026, on revenue of $7,291m. The year before it reported a net profit of $798.0m.
- Does Bath & Body Works pay a dividend?
- In fiscal 2026, Bath & Body Works paid $167.0m in dividends, 25.7% of its net profit, according to its cash flow statement.
- What are the earnings per share of Bath & Body Works?
- They were $3.12 in fiscal 2026, compared with $3.62 the year before.
- Where is Bath & Body Works listed?
- Bath & Body Works is listed on the New York Stock Exchange under the ticker BBWI and belongs to the consumer discretionary sector.
- Where do the figures for Bath & Body Works come from?
- From the annual report (Form 10-K) that Bath & Body Works files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
The annual accounts come from the annual report (Form 10-K) that Bath & Body Works files with the SEC, the US securities regulator. Each fiscal year in the table links to its filing. Celsmar reads the tagged figures from the document and does not adjust them: if an item is not in the filing, it is not shown. More detail in data sources and, if you spot an error, in corrections. What Celsmar is and what it costs, in its fact sheet.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.